Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan 150mg vs 300mg in Chinese Hypertensive Patients with Diabetes
NCT00334581Phase 4Completed
- Sponsor
- Sanofi
- Start
- May 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of irbesartan in hypertension (HTN), diabetic nephropathy (DN), sponsored by Sanofi. Started May 2006; status: completed.
02
Drugs
irbesartan
03
Conditions
hypertension (HTN)diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00334581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334581.